Description
Composition- Linagliptin 5 mg
Mode of Action- DPP-4 inhibitor that prolongs incretin activity, enhancing glucose-dependent insulin release and reducing glucagon secretion.
USPs- Effective oral antidiabetic support; low hypoglycemia risk; useful in type 2 diabetes management.
Prescribing Specialties- Diabetologist, General Physician, Internal Medicine
